pluri.jpg
Pluri’s Business Verticals Gain Traction in Global Markets; Leadership to Participate and Present in Upcoming Conferences
March 28, 2024 07:15 ET | Pluri Inc.
HAIFA, Israel, March 28, 2024 (GLOBE NEWSWIRE) -- Pluri Inc. (Nasdaq:PLUR) (TASE:PLUR) ("Pluri" or "the Company"), a leading biotechnology company that transforms cells into solutions that promote...
Gilat Logo Full Color.png
Gilat Awarded $5 Million Order from the US Department of Defense
March 28, 2024 07:06 ET | Gilat Satellite Networks Ltd.
PETAH TIKVA, Israel, March 28, 2024 (GLOBE NEWSWIRE) -- Gilat Satellite Networks Ltd. (Nasdaq: GILT, TASE: GILT), a worldwide leader in satellite networking technology, solutions, and services,...
Xilio_Full_CLR_Logo_CMYK.png
Xilio Therapeutics Announces $11.3 Million Private Placement Equity Financing
March 28, 2024 07:05 ET | Xilio Therapeutics, Inc.
Announces strategic portfolio reprioritization focused on rapid advancement of clinical-stage programs for XTX301, a tumor-activated, IL-12, and XTX101, a tumor-activated, Fc-enhanced anti-CTLA-4, and...
Shimmick Corporation Announces Fourth Quarter and Fiscal Year 2023 Results
March 28, 2024 07:00 ET | Shimmick Corporation
IRVINE, Calif., March 28, 2024 (GLOBE NEWSWIRE) -- Shimmick Corp. (NASDAQ: SHIM), a leading water infrastructure company, today announced financial results for the fiscal year ended December 29,...
NEW ATAI-Logo_Primary.png
atai Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate and Clinical Highlights
March 28, 2024 07:00 ET | atai Life Sciences
Strategic investment in Beckley Psytech to accelerate the development of psychedelic-based therapies that fit within the two hour in-clinic treatment paradigm established by Spravato®Initial BPL-003...
stran.png
Stran & Company Reports 28.7% Increase in Sales and Achieves Profitability for the 2023 Fiscal Year
March 28, 2024 07:00 ET | Stran & Company, Inc.
Benefitting from Increased Operating Efficiency and Economies of Scale, Evidenced by 156% Year-Over-Year Increase in Operating Income for the Fourth Quarter of 2023 Reports Net Earnings of $883,000...
Galera®-logo.jpg
Galera Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Updates
March 28, 2024 07:00 ET | Galera Therapeutics
MALVERN, Pa., March 28, 2024 (GLOBE NEWSWIRE) -- Galera Therapeutics, Inc. (Nasdaq: GRTX), a biopharmaceutical company focused on developing a pipeline of novel, proprietary therapeutics that have...
Milestone Pharmaceuticals Logo.png
Milestone Pharmaceuticals Announces Resubmission of New Drug Application for Etripamil for Treatment in Paroxysmal Supraventricular Tachycardia
March 28, 2024 07:00 ET | Milestone Pharmaceuticals Inc.
MONTREAL and CHARLOTTE, N.C., March 28, 2024 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of...
Hi ECARX20221221-204233.png
ECARX Partners with Lianyou Zhilian to Accelerate Development of Intelligent Vehicle Solutions
March 28, 2024 07:00 ET | ECARX LIMITED; Lianyou Zhilian
SHANGHAI, China, March 28, 2024 (GLOBE NEWSWIRE) -- ECARX Holdings Inc. (Nasdaq: ECX) (“ECARX” or the “Company”), a global mobility technology provider, today announced a strategic partnership with...
TilrayBrands_Logo_FullColor_RBG_Horiz-01.png
Tilray Brands, Inc. to Announce Third Quarter 2024 Financial Results on April 9, 2024
March 28, 2024 07:00 ET | Tilray Brands, Inc.
Tilray Brands will release financial results for its third quarter ended February 29, 2024, on April 9, 2024.